, Tracking Stock Market Picks
Enter Symbol:
Pozen, Inc. (POZN) [hlAlert]

up 10.09 %

Pozen, Inc. (POZN) rated Buy with price target $11 by C.K. Cooper

Posted on: Thursday,  Apr 26, 2012  8:25 AM ET by C.K. Cooper

C.K. Cooper rated Buy Pozen, Inc. (NASDAQ: POZN) on 04/26/2012, when the stock price was $8.02. Since
then, Pozen, Inc. has gained 10.10% as of 01/25/2016's recent price of $8.83.
If you would have followed this C.K. Cooper's recommendation on POZN, you would have gained 10.09% of your investment in 1369 days.

Pozen Inc. is pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. Its initial area of focus is migraine, where the company have built a portfolio of four product candidates through a combination of innovation and in-licensing. Its lead product candidate is MT 100, which the company is developing as an oral first-line therapy for the treatment of migraine.

C. K. Cooper & Company has for over a decade provided insightful research ideas and commentary. As the firm identifies focus industries it brings together an analytical team to provide unique vision and insight to select investment ideas. In addition, leveraging on the expertise of the firm, the Research Team can evaluate opportunities against a wide database of industry and competitive trends.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/26/2012 8:25 AM Buy
8.02 11.00
as of 12/31/2012
1 Week down  -2.71 %
1 Month down  -9.72 %
3 Months down  -24.43 %
1 YTD down  -37.53 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy